You searched for "procedures"

5772 results found

Altomed announces attendance at RCOphth

Altomed are pleased to confirm they will be attending RCOphth congress in May with their ever-popular hands-on workstations and practice lab. Once again, they will have the much talked about Malyugin Ring #fastestestringer challenge, SimulEYE training models and try before...

Mastering Monovision with Professor Graham Barrett and Mr Alastair Stuart

Professor Graham Barrett, creator of RayOne EMV, joins Mr Alastair Stuart, Medical Director of Optegra UK, to discuss why he frequently selects this lens for patients in Rayner’s Peer2Peer podcast series. Mr Stuart shares insights on patient selection, calculations, and...

Mainline Instruments Partners with InMode to bring ENVISION to the UK & Ireland

We are excited to entering our new partnership with InMode, a global leader in medical technologies, to distribute the ENVISION Dry Eye care platform across the UK and Ireland. Envision is a state-of-the-art system that combines IPL and Radiofrequency to...

A lifelong commitment to ophthalmology

Altomed is the largest independent supplier to the UK ophthalmic surgical sector. We manufacture and distribute over 3,000 high-quality products, including reusable instruments, single use devices and consumables, sterilisation trays, implants, liquids and gases and simulation training models. Altomed are...

Altomed 2025 MST Malyugin Ring Challenge – Winners Announced!

Thank you to everyone who stopped by the Altomed stand at the recent RCO Congress and participated in the 2025 #MalyuginRingChallenge. We are pleased to share the final results: Myles Potter. 1st Myles Potter, from Royal Devon and Exeter Hospital,...

Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch

Nordic group B.V – an international pharmaceutical company operating as Nordic Pharma have received CE mark approval for Lacrifill®, a novel dry eye therapy. Lacrifill® is a cross-linked hyaluronic acid gel that temporarily blocks tear drainage by occluding the canalicular...

Heidelberg Engineering announces partnership with Hospital Services Ltd for distribution and service in Ireland

Heidelberg Engineering is excited to announce a strategic partnership with Hospital Services Ltd (HSL), which will take over as the exclusive distributor and service provider of the Heidelberg Engineering range of products in the Republic of Ireland, effective 1st July...

New Online Ophthalmology Portfolio Points Calculator

Applying for Ophthalmology ST1 is a competitive and often stressful process, with many applicants finding the portfolio self-assessment scoring system difficult to navigate. To make this process easier, a new online tool - MedPoints - has been developed to give...

Sight Sciences at ESCRS

The Sight Sciences team recently returned from an incredibly busy and successful ESCRS congress in Copenhagen. The team were in town to support the MIGS masterclass programme and were pleased to spend time with customers, colleagues and contacts from across...

Eye Juniors Introduction to the ST1 Application 2025-26

Join Eye Juniors for their Introduction to ST1 Ophthalmology Application 2025-2026. In this free talk high scoring trainees will talk you through the entire ST1 application process – from the MSRA and portfolio to the interview. They’ve been running the...

Effect of intra-arterial chemotherapy drug regimens on globe salvage outcomes of retinoblastoma patients

This is a retrospective study from Shandong University, China, between May 2016 to November 2019, to compare the effect of 3-drug regimen (melphalan (MP) , topotecan (TP) and Carboplatin (CP)) of 95 patients (97 eyes) with two-drug regimen (MP and...

Understanding the pachychoroid disease spectrum

This article provides a comprehensive review of the pachychoroid disease spectrum, a group of chorioretinal disorders characterised by abnormal choroidal thickening and various pathological changes in the choroid, retinal pigment epithelium, and retina. It also highlights the controversies and knowledge...